John Wood Group PLC
LSE:WG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
John Wood Group PLC
LSE:WG
|
UK |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
M
|
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
|
US |
|
Lefroy Exploration Ltd
ASX:LEX
|
VG |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
DE |
|
A
|
Astor Enerji AS
IST:ASTOR.E
|
TR |
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
SE |
|
BTS Group AB
OTC:BGPBF
|
SE |
|
M
|
Marks and Spencer Group PLC
SWB:MA6
|
UK |
|
Nostra Terra Oil and Gas Company PLC
LSE:NTOG
|
UK |
|
P
|
Prosus NV
JSE:PRX
|
NL |
|
N
|
Nok Airlines PCL
SET:NOK
|
TH |
|
O
|
Orcay Ortakoy Cay Sanayi ve Ticaret AS
IST:ORCAY.E
|
TR |
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
Advicenne SA
PAR:ALDVI
|
FR |
|
Autosports Group Ltd
ASX:ASG
|
AU |
Wall Street
Price Targets
WG Price Targets Summary
John Wood Group PLC
According to Wall Street analysts, the average 1-year price target for
WG
is 45.9 GBX
with a low forecast of 30.3 GBX and a high forecast of 63 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WG's stock price target?
Price Target
45.9
GBX
According to Wall Street analysts, the average 1-year price target for
WG
is 45.9 GBX
with a low forecast of 30.3 GBX and a high forecast of 63 GBX.
What is John Wood Group PLC's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
John Wood Group PLC's revenue is
0%.
The projected
CAGR
for the next 3 years is
1%.
